Trastuzumab in patients with breast cancer and pre-existing left ventricular systolic dysfunction

被引：0
作者：
Azin Alizadehasl
Mina Mohseni
Kamran Roudini
Parisa Firoozbakhsh
机构：
[1] Iran University of Medical Sciences,Cardio
[2] Imam Khomeini Hospital Complex,Oncology Research Center, Rajaie Cardiovascular Medical and Research Center
[3] Tehran University of medical Sciences,Department of Internal Medicine, Hematology and Medical Oncology Ward, Cancer Research Center, Cancer Institute
来源：
Cardio-Oncology | / 10卷
关键词：
Trastuzumab; Left ventricular dysfunction; Cardiotoxicity; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The Role of Selvester Score on 12-Lead ECG in Determination of Left Ventricular Systolic Dysfunction Among Patients Receiving Trastuzumab Therapy
    Ciftci, Orcun
    Yilmaz, Kerem Can
    Karacaglar, Emir
    Akgun, Arzu Neslihan
    Yilmaz, Mustafa
    Oguz, Arzu
    Muderrisoglu, Ibrahim Haldun
    EUROPEAN JOURNAL OF THERAPEUTICS, 2019, 25 (01): : 69 - 75
  • [22] Comment on "Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer" Reply
    Kim, Kye Hun
    JOURNAL OF BREAST CANCER, 2017, 20 (01) : 112 - 113
  • [23] Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction
    Hussain, Yasin
    Drill, Esther
    Dang, Chau T.
    Liu, Jennifer E.
    Steingart, Richard M.
    Yu, Anthony F.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (01) : 239 - 246
  • [24] Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study
    Dhir, Vinita
    Yan, Andrew T.
    Nisenbaum, Rosane
    Sloninko, Joanna
    Connelly, Kim A.
    Barfett, Joseph
    Haq, Rashida
    Kirpalani, Anish
    Chan, Kelvin K. W.
    Petrella, Teresa M.
    Brezden-Masley, Christine
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2019, 35 (11) : 2085 - 2093
  • [25] Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction
    Yasin Hussain
    Esther Drill
    Chau T. Dang
    Jennifer E. Liu
    Richard M. Steingart
    Anthony F. Yu
    Breast Cancer Research and Treatment, 2019, 175 : 239 - 246
  • [26] Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study
    Vinita Dhir
    Andrew T. Yan
    Rosane Nisenbaum
    Joanna Sloninko
    Kim A. Connelly
    Joseph Barfett
    Rashida Haq
    Anish Kirpalani
    Kelvin K. W. Chan
    Teresa M. Petrella
    Christine Brezden-Masley
    The International Journal of Cardiovascular Imaging, 2019, 35 : 2085 - 2093
  • [27] Predictors of early left ventricular systolic dysfunction in duchenne muscular dystrophy patients
    Dea Cirino, Raphael Henrique
    Scola, Rosana Herminia
    Ducci, Renata Dal-Pra
    Camarozano Wermelinger, Ana Cristina
    Kamoi Kay, Claudia Suemi
    Lorenzoni, Paulo Jose
    Werneck, Lineu Cesar
    Carmes, Eliane Ribeiro
    Pereira Da Cunha, Claudio Leinig
    MUSCLE & NERVE, 2018, 58 (01) : 84 - 89
  • [28] Cardiac toxicity of trastuzumab in elderly patients with breast cancer
    Denegri, Andrea
    Moccetti, Tiziano
    Moccetti, Marco
    Spallarossa, Paolo
    Brunelli, Claudio
    Ameri, Pietro
    JOURNAL OF GERIATRIC CARDIOLOGY, 2016, 13 (04) : 355 - 363
  • [29] Reversible Left Ventricular Systolic Dysfunction Secondary to Pazopanib
    Gajjar, Kushani
    Balakumaran, Kathir
    Kim, Agnes S.
    CUREUS, 2018, 10 (10):
  • [30] Evaluation of Subtle Left Ventricular Systolic Dysfunction by Longitudinal Systolic Strain in Patients with Human Immunodeficiency Virus
    Cetin, Sukru
    Gunduz, Alper
    Cetin, Ayse Sababli
    Gurdal, Ahmet
    Sumerkan, Mutlu Cagan
    Yildiz, Suleyman Sezai
    Uzun, Nuray
    Kilickesmez, Kadriye Orta
    ACTA CARDIOLOGICA SINICA, 2018, 34 (04) : 321 - 327
12345